Beta Bionics Announces Partnership With Abbott to Integrate the iLet Bionic Pancreas With the FreeStyle Libre 3 Plus iCGM

September 4, 2024 8:00 AM

IRVINE, CA / ACCESSWIRE / September 4, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced today they are working to integrate Abbott's glucose sensing technology with the iLet Bionic Pancreas automated insulin delivery system.Beta Bionics' flagship product, the iLet Bionic Pancreas, is an autonomous insulin delivery system that streamlines diabetes management and reduces the...

Read more

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

September 4, 2024 8:00 AM

FORT LAUDERDALE, FL / ACCESSWIRE / September 4, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced the publication of new research results in the Journal of Medicinal Chemistry. The published data demonstrate a novel PLpro inhibitor with submicromolar potency and in vivo efficacy...

Read more

Revelstoke Capital Partners Announces Significant Growth Investment in MediQuant

September 4, 2024 8:00 AM

DENVER, CO and INDEPENDENCE, OH / ACCESSWIRE / September 4, 2024 / Revelstoke Capital Partners ("Revelstoke"), a healthcare-focused private equity firm, today announced a significant growth investment in MediQuant, LLC ("MediQuant" or the "Company"), a leader in cloud-based data archiving and interoperability solutions for hospitals and health systems. MediQuant is the seventh investment from Revelstoke Capital Partners Fund III. Terms of the...

Read more

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications

September 4, 2024 7:30 AM

Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), a pre-clinical-stage company seeking to lead developments in longevity science through the treatment of age-related conditions, is pleased to announce the appointment of Dr. Itzchak Angel as Chief Scientific Advisor.Dr. Angel, in collaboration with Telomir's senior management, will look to expedite the pre-clinical and clinical path of Telomir's lead product candidate,...

Read more

As Research into Pain Accelerates, a Newly Recognized Type of Pain Comes to the Forefront - Tonix Targets it with FDA-Fast Track-Designated TNX-102 SL

September 4, 2024 7:00 AM

CHATHAM, NJ / ACCESSWIRE / September 4, 2024 / This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations work to ensure that any and all information contained within is true and accurate as of the date hereof to the best of their knowledge and research. This content is for informational purposes only...

Read more

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

September 4, 2024 7:00 AM

Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) has reported its financial results for the second quarter ended July 31, 2024. The Company reported a strong cash position at quarter end, reinforcing its ability to advance the development of its lead product, AVERSA™ Fentanyl, with an NDA submission targeted for the first half of 2025.Nutriband is expanding its kinesiology tape contract manufacturing services through its Pocono Pharma subsidiary, with...

Read more

New SmartBadges Enhance School Safety Environment

September 4, 2024 6:00 AM

Palarum SmartBadge Technology Improves Staff and Student Safety at Mason, Ohio, SchoolMASON, OH / ACCESSWIRE / September 4, 2024 / Faculty, administrators and staff are all too aware of the dangerous and sometimes deadly events that have beset the nation's schools. Most safety incidents at schools involve low-threat level events, such as a stranger lurking near school grounds, unidentified visitors walking through the halls or fights breaking...

Read more

NovaSight Announces Publication of Study Showing CureSight’s Superiority Over Patching

September 4, 2024 5:00 AM

Patients Using the CureSight Digital Eye-Tracking Device for Amblyopia Treatment Achieved Significantly Greater Visual Acuity Gains in Per-Protocol AnalysisAIRPORT CITY, ISRAEL / ACCESSWIRE / September 4, 2024 / NovaSight, a rapidly growing pediatric-focused eyecare company, is pleased to announce publication of "High-adherence dichoptic treatment versus patching in anisometropic and small angle strabismus amblyopia: a randomized controlled...

Read more

Ascelia Pharma Announces Preliminary Outcome in Rights Issue

September 4, 2024 1:50 AM

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES PURSUANT TO APPLICABLE LAW.MALMÖ, SWEDEN /...

Read more

IRLAB is Granted Additional Patent for Drug Candidate Mesdopetam that Expands its Patent Protection

September 4, 2024 1:20 AM

GOTHENBURG, SWEDEN / ACCESSWIRE / September 4, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, September 4, 2024 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company has been granted a new patent in Europe, which includes a new salt of mesdopetam used throughout the clinical development process and the process of...

Read more

Revolutionary Hypnotherapy Technique Emerges as the #1 Method to Quit Nicotine - Changing the Game in Behavioral Health

September 3, 2024 9:15 PM

In a groundbreaking development for those struggling with nicotine addiction, NicFree introduces a new hypnotherapy approach that is quickly becoming recognized as the most effective way to kick the habit for good. Led by renowned hypnotherapist Jordan Lally, the practice is at the forefront of using advanced hypnotherapy techniques not only to combat nicotine dependence but also to facilitate profound and lasting changes in other behavioral...

Read more

CORRECTION: Enable Me Reminds Mammography Professionals that When the New MQSA Becomes Effective Next Week, Compliance Will Include Major Emphasis on Mammogram Digital Image Quality

September 3, 2024 3:50 PM

Enable Me, a VELA Medical company, reminds the mammography profession that when the new Mammography Quality Standards Act (MQSA) becomes effective Sept. 10, among its most rigorous requirements are clearer images resulting in fewer retakes. The term "image quality" is mentioned 12 times in the 46-page text of the new MQSA, often referring to the requirement as an aspect of facility performance that, if unmet, could be a factor in...

Read more

EnClear Therapies, Inc. Secures Additional Funding to Advance Neuro-Oncology Innovations

September 3, 2024 2:00 PM

EnClear Therapies, Inc., an early-stage neurotechnology innovator, is excited to announce the successful closing of its latest financing round.In this round, EnClear has expanded its neuro-oncology-focused funding base with investments from new partners including the Brain Tumor Investment Fund and the Sontag Innovation Fund. The round also saw continued support from existing investors such as Amgen Ventures, Founders Fund, Thiel Bio Fund,...

Read more

Enable Me Reminds Mammography Professionals that When the New MQSA Becomes Effective Next Week, Compliance Will Include Major Emphasis on Mammogram Digital Image Quality

September 3, 2024 12:40 PM

Enable Me, a VELA Medical company, reminds the mammography profession that when the new Mammography Quality Standards Act (MQSA) becomes effective Sept. 10, among its most rigorous requirements are clearer images resulting in fewer retakes.The term "image quality" is mentioned 12 times in the 46-page text of the new MQSA, often referring to the requirement as an aspect of facility performance that, if unmet, could be a factor in...

Read more

Safe Haven Baby Boxes Launches Groundbreaking Reality Series 'Baby Boxes'

September 3, 2024 11:00 AM

WOODBURN, IN / ACCESSWIRE / September 3, 2024 / Safe Haven Baby Boxes is thrilled to announce the launch of our brand-new reality series, "Baby Boxes." This series takes viewers behind the scenes showcasing the inspiring and often outspoken team members who make our life-saving work possible.Safe Haven Baby Boxes The series' debut exceeded all our expectations, reaching more households than we ever imagined! On the night of Episode One's...

Read more

Humonix Bio Announces Appointment of Thurein Htoo as Chairman of the Board of Directors and Welcomes Christie Markowitz as New Independent Board Director

September 3, 2024 10:30 AM

ALBANY, NY / ACCESSWIRE / September 3, 2024 / Humonix Biosciences, Inc., a leading specialty pharmaceutical research company, is pleased to announce the appointment of Thurein Htoo as the new Chairman of the Board of Directors. The company also warmly welcomes Christie Markowitz as its newest board director. Mr. Htoo steps into the role of Chairman of the Board following a distinguished tenure on the board and brings with him a wealth of...

Read more

Formula Wellness Partners with Radiance Medical Aesthetics & Wellness, Expanding Longevity Services in The Woodlands, TX

September 3, 2024 9:00 AM

Formula Wellness proudly announces its partnership with Radiance Medical Aesthetics & Wellness, a premier destination for advanced medical aesthetic treatment and skincare in The Woodlands, Texas. This strategic move underscores Formula Wellness' commitment to integrating comprehensive patient wellness and aesthetic services to augment patient health, facial and body aesthetics, and longevity.The founder of Radiance Medical Aesthetics &...

Read more

OccuPro Launches Revolutionary Functional Capacity Evaluation 4.0 Software

September 3, 2024 9:00 AM

The latest version offers enhanced efficiency, advanced features, and a seamless user experience to streamline functional capacity evaluations worldwide.KENOSHA, WI / ACCESSWIRE / September 3, 2024 / OccuPro, the industry's most respected workers' compensation documentation system, is excited to announce the launch of its highly anticipated Functional Capacity Evaluation (FCE) 4.0 software. This next-generation platform is designed to...

Read more

Glen and Michelle Scharfeld of Senior Helpers Featured in an Insightful Online Interview Discussing Their Pioneering Work

September 3, 2024 8:45 AM

Glen and Michelle Scharfeld, co-owners of Senior Helpers, a leading multi-territory in-home care service operating in the Nature Coast and Sun Coast areas, were recently featured in a comprehensive online interview. They shared deep insights into their motivation, the challenges they face, and the impactful solutions they provide for seniors and veterans through their organization.With a rich history in law enforcement and the legal field...

Read more

Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention

September 3, 2024 8:30 AM

Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an innovative healthcare company focused on advanced AI-driven point-of-care testing (POCT) and low-dose interferon therapeutics, is pleased to announce that its groundbreaking VELDONA® formulation has been granted an invention patent in Taiwan and has filed for global patent protection under the Patent Cooperation Treaty (PCT). This patent represents a significant milestone in...

Read more